Concerns
on nitrated polycyclic aromatic hydrocarbons (nitro-PAHs)
in the environment have mainly arisen from their mutagenic and carcinogenic
effects. The objective of this study is to investigate whether nitro-PAH
exposures are associated with biomarkers of cardiovascular pathophysiology.
In a panel study design, urines and blood samples were collected up
to four times with a 2-week interval from 89 healthy adults. We measured
1-naphthylamine, 2-naphthylamine, 9-aminophenanthrene, 2-aminofluorene,
and 1-aminopyrene as biomarkers of nitro-PAH exposures. We measured
three urinary metabolites of arachidonic acid (AA) including 20-hydroxyeicosatetraenoic
acid (20-HETE) from the cytochrome P450 (CYP) pathway, 8-isoprostane
from the nonenzymatic pathway, and 11-dehydro-thromboxane B2 (11-dhTXB2) from the cyclooxygenase (COX) pathway. Urinary malondialdehyde,
8-hydroxy-2′-deoxyguanosine (8-OHdG), and 6-sulfatoxymelatonin
(aMT6s) were measured to reflect systemic oxidative stress. Plasma
concentrations of the soluble P-selectin and von Willebrand factor
(vWF) were measured as biomarkers of platelet activation and endothelial
dysfunction. We found that increased urinary concentrations of amino-PAHs
were significantly associated with increased 20-HETE, 11-dhTXB2, and 8-OHdG and with decreased 8-isoprostane and aMT6s. Increased
amino-PAHs were positively associated with P-selectin and vWF, respectively.
These results suggest that exposure to nitro-PAHs increases systemic
oxidative stress and alters AA metabolism toward CYP and COX pathways,
leading to an increased cardiovascular disease risk.